SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS EX - Post-effective amendment adding exhibits to registration statement [Rule 462(d)]:
SEC Accession No. 0001493152-23-017907
Filing Date
2023-05-17
Accepted
2023-05-17 10:52:15
Documents
6
Effectiveness Date
2023-05-17

Document Format Files

Seq Description Document Type Size
1 formposex.htm POS EX 59283
2 ex4-12.htm EX-4.12 108849
3 ex4-13.htm EX-4.13 111852
4 ex4-14.htm EX-4.14 111837
5 ex4-15.htm EX-4.15 119287
6 ex10-16.htm EX-10.16 248829
  Complete submission text file 0001493152-23-017907.txt   761059
Mailing Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037
Business Address 7946 IVANHOE AVENUE SUITE 201 LA JOLLA CA 92037 (858) 263-4196
Ensysce Biosciences, Inc. (Filer) CIK: 0001716947 (see all company filings)

IRS No.: 822755287 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS EX | Act: 33 | File No.: 333-271480 | Film No.: 23930208
SIC: 2834 Pharmaceutical Preparations